DK3204767T3 - Proteins anvendelighed i forudsigelsen af in vivo-effekter - Google Patents

Proteins anvendelighed i forudsigelsen af in vivo-effekter

Info

Publication number
DK3204767T3
DK3204767T3 DK15848390.9T DK15848390T DK3204767T3 DK 3204767 T3 DK3204767 T3 DK 3204767T3 DK 15848390 T DK15848390 T DK 15848390T DK 3204767 T3 DK3204767 T3 DK 3204767T3
Authority
DK
Denmark
Prior art keywords
predicting
usefulness
proteins
vivo effects
vivo
Prior art date
Application number
DK15848390.9T
Other languages
English (en)
Inventor
Kenneth R Brouwer
Christopher B Black
Jonathan P Jackson
Original Assignee
Qualyst Transp Solutions Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Qualyst Transp Solutions Llc filed Critical Qualyst Transp Solutions Llc
Application granted granted Critical
Publication of DK3204767T3 publication Critical patent/DK3204767T3/da

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5067Liver cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/10Screening for compounds of potential therapeutic value involving cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
DK15848390.9T 2014-10-07 2015-10-07 Proteins anvendelighed i forudsigelsen af in vivo-effekter DK3204767T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462060916P 2014-10-07 2014-10-07
PCT/US2015/054411 WO2016057626A1 (en) 2014-10-07 2015-10-07 Utility of protein in the prediction of in vivo effects

Publications (1)

Publication Number Publication Date
DK3204767T3 true DK3204767T3 (da) 2025-11-24

Family

ID=55653702

Family Applications (1)

Application Number Title Priority Date Filing Date
DK15848390.9T DK3204767T3 (da) 2014-10-07 2015-10-07 Proteins anvendelighed i forudsigelsen af in vivo-effekter

Country Status (11)

Country Link
US (1) US20170205393A1 (da)
EP (2) EP4509835A3 (da)
JP (5) JP7097697B2 (da)
CN (4) CN119932147A (da)
AU (3) AU2015328138A1 (da)
CA (1) CA2962491C (da)
DK (1) DK3204767T3 (da)
FI (1) FI3204767T3 (da)
IL (1) IL251605B (da)
MA (1) MA41048A (da)
WO (1) WO2016057626A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109964129B (zh) * 2016-09-16 2023-04-14 库里斯特转运体解决方案有限责任公司 用于筛选候选化合物引起全身性毒性或肝毒性的潜能的方法和系统
CN116529390A (zh) * 2020-11-25 2023-08-01 Jsr株式会社 评价被验物质通过人肝细胞样细胞而排出的方法
US20240125807A1 (en) * 2020-12-18 2024-04-18 Chugai Seiyaku Kabushiki Kaisha METHOD FOR MEASURING RELATIVE fu RATIO BY DYNAMIC ANALYSIS
JP2025525599A (ja) * 2022-07-20 2025-08-05 シンバイオセルテック・エルエルシー 細胞の増殖のための種特異的組織培養培地
JP7837620B2 (ja) * 2025-07-25 2026-03-31 株式会社大都技研 遊技台
JP7837628B2 (ja) * 2025-07-25 2026-03-31 株式会社大都技研 遊技台

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US411077A (en) * 1889-09-17 Hugh garment turley
US4110077A (en) 1976-10-08 1978-08-29 Hoffmann-La Roche Inc. Determination of β-lipoproteins in blood serum with polyanethole sulfonate
ATE323283T1 (de) 1999-03-17 2006-04-15 Univ North Carolina Screening-verfahren von kandidaten verbindungen für empfindlichkeit gegenüber gallenexkretion
US7601494B2 (en) 1999-03-17 2009-10-13 The University Of North Carolina At Chapel Hill Method of screening candidate compounds for susceptibility to biliary excretion
US6458589B1 (en) * 2000-04-27 2002-10-01 Geron Corporation Hepatocyte lineage cells derived from pluripotent stem cells
JP4913030B2 (ja) * 2005-01-31 2012-04-11 株式会社バイオセレンタック 経皮吸収製剤、経皮吸収製剤保持シート、及び経皮吸収製剤保持用具
WO2007146203A1 (en) 2006-06-08 2007-12-21 The University Of North Carolina At Chapel Hill Pulsing of bile compartments in sandwich-cultured hepatocytes
US20130115271A1 (en) * 2010-04-19 2013-05-09 The University Of North Carolina At Chapel Hill Predictors of pharmacokinetic and pharmacodynamic disposition of carrier-mediated agents

Also Published As

Publication number Publication date
IL251605A0 (en) 2017-06-29
EP3204767A1 (en) 2017-08-16
CN119932146A (zh) 2025-05-06
JP2025124643A (ja) 2025-08-26
JP2023098948A (ja) 2023-07-11
CN107003299A (zh) 2017-08-01
EP3204767A4 (en) 2018-02-28
CN119753076A (zh) 2025-04-04
IL251605B (en) 2022-01-01
AU2024204363A1 (en) 2024-07-11
MA41048A (fr) 2017-08-15
US20170205393A1 (en) 2017-07-20
WO2016057626A1 (en) 2016-04-14
CA2962491A1 (en) 2016-04-14
JP2025160199A (ja) 2025-10-22
EP4509835A3 (en) 2025-05-28
JP7097697B2 (ja) 2022-07-08
CN119932147A (zh) 2025-05-06
EP4509835A2 (en) 2025-02-19
CA2962491C (en) 2023-03-21
JP2017532066A (ja) 2017-11-02
JP2020182475A (ja) 2020-11-12
EP3204767B1 (en) 2025-09-10
FI3204767T3 (fi) 2025-11-28
AU2021269341A1 (en) 2021-12-09
AU2015328138A1 (en) 2017-04-27

Similar Documents

Publication Publication Date Title
IL254516A0 (en) Proteins specific for cd137
IL254039A0 (en) Anti-pvrig antibodies and methods of use
IL257170B (en) Stable proteins and methods for designing same
PL3353210T3 (pl) Przeciwciała anty-TIGIT i sposoby stosowania
DK3160994T3 (da) Multispecifikke antigenbindende proteiner
EP3397764A4 (en) DIGITAL PROTEIN QUANTIFICATION
DK3137169T3 (da) Hæmmere af lysin-specifik demethylase-1
DK3313876T3 (da) Multispecifikke antigenbindende proteiner
PT3215532T (pt) Anticorpos anti-tim3 e métodos de utilização
DK2970954T3 (da) Modifikation af polypeptider
DK3180363T3 (da) Sirp-alpha-immunoglobulin fusionsproteiner
DK3556777T3 (da) Multispecifikke antistofkonstrukter
PL3148579T3 (pl) Przeciwciała anty-gitr i sposoby ich zastosowania
ME03558B (me) Molekuli anti-lag-3 antiтela i njihove upotrebe
DK3126395T3 (da) Multispecifikke antistoffer
DK2951203T3 (da) Heterodimere proteiner
DK3102576T3 (da) Dihydropyrrolopyridininhibitorer af ror-gamma
DK3164380T3 (da) Hæmmere af lysinspecifik demethylase-1
DK3347450T3 (da) Ex vivo-proliferation af epithelceller
DK3197472T3 (da) Rekombinante phe-frie proteiner til anvendelse i behandlingen af phenylketonuri
DK3094322T3 (da) Administration af tasimelteon i fastende tilstand
DK3092003T3 (da) Hidtil ukendt anti-netrin-1-antistof
DK3702450T3 (da) Protein
DK3204352T3 (da) Hæmmere af lysin-gingipain
DK3418273T3 (da) Derivater af flavagliner